Pfizer Inc., New York, is reviewing the external managers for its $2.9 billion defined benefit plan and the $1.1 billion defined benefit plan of Pharmacia Corp., Peapack, N.J., which it acquired last month. Manager changes may result. Pfizer spokesman Paul Fitzhenry said Pfizer officials plan to devise an optimum structure for the business; details were not available.
Separately, Patricia Haverland, senior director of pension investments at Pharmacia and Charles Malone, manager of pension investments, lost their jobs. Sharon Kinsman, assistant treasurer at Pfizer, and Mr. Fitzhenry would not comment. Ms. Haverland and Mr. Malone also declined to comment.